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Medicinal use compared with Laboratory research: Relation of traditional sceince and modern science 
by Brendan Walshe Rouusel 
Introduction 
Official recognition of traditional medicine by the local medical community is hampered by lack of validation of safety and efficacy of 
traditional medicine. In our retrospective study with the healers, one of their most frequent requests was the scientific validation of 
their traditional medicine, so that it receives the respect of the western trained medical community. We therefore proposed the use of 
quantitative ethnobotany to select key medicinal plants with the healers for  validation of  medicinal activity  at the University of 
Ottawa Medicinal Plant laboratory. In the present study we evaluated ethnobotanical selected  products for  inflammatory conditions, 
since the Kekchi healers have considerable expertise in this area and it is also considered an appropriate area for self medication by 
regulatory authorities. The second was a broad search of other agents including topical anti-infective agents, such as products used for 
minor fungal or bacterial infections like athletes foot, or impetigo which are also widely and successfully used by the healers. We 
tested the hypothesis that healer consensus is a good predictor of medicinal activity 
Methods 
Plant Extraction techniques 
To obtain a compete spectrum of relevant phytochemicals, both water and 95% ethanol extracts were prepared. Most 
indigenous botanical therapies are prepared by water extraction, often involving a lengthy simmering or boiling period. Ethanolic 
extracts are a staple of modern extraction techniques, as the extract produced contains a wide array of phytochemicals of medium 
polarity. In order to ensure extract standardization, raw plant material was extracted at a constant ratio of 1g of plant material to 10 ml 
of extraction solvent.  The boiled water extract and the 95% EtOH extract were extracted in duplicate, and underwent sonnication, 




THP-1 cells (www.ATCC.org, cell culture TIB-202), an immortal human monocyte line, were cultured in RPMI 1640 media 
(Invitrogen, Mississauga, Ontario) with 1% 0.05mM beta-mercaptoethanol, 1% penstrep (Invitrogen, Mississauga, Ontario), 10% fetal 




Extract toxicity will be established using Promega’s CytoTox 96® Non-Radioactive Cytotoxicity Assay (Madison, Wisconsin), 
which examines the release of lactate dehydrogenase as an indicator of cell viability. 
 
Pro-inflammatory and anti-inflammatory assay 
3 x 105 THP-1 cells are added to the wells of a 96-well plate, followed by the addition of botanical water and ethanol extracts of 
various concentrations for a total volume of 300ul/well. In both pro- and anti-inflammatory bioassays a botanical and a non-botanical 
positive control were used. With the ethanolic treatments, final EtOH concentration in the wells is 0.5%. In the pro-inflammatory 
assays, cells are then incubated for 24 hours. In the anti-inflammatory assays, cells are incubated for 1 hour, then stimulated with 
1ug/ml LPS and allowed to incubate for 24 hours. After incubation, all cells are centrifuged at 12 000g for 10 minutes at 20°C. Cell 
culture pellets and supernatants are separated and stored at -80°C for subsequent analysis.  ELISA kits (R & D Systems, Minneapolis, 
Minnesota) were used according to the manufacturer’s protocol to analyze TNF-α levels in pro- and anti-inflammatory macrophage 
bioassay supernatants.   
 
Microbial strains and inoculum preparation 
 All yeast like fungi are all opportunistic humain pathogens (Table 3).   Fungi were cultured on Sabouraud dextrose agar 
medium at 30 ºC.  Prior to the assay, yeast-like fungi were grown in a liquid Sabouraud dextrose broth at 30 ºC. The culture was 
subsequently adjusted to an O.D.600 of 2.0 and diluted to 1:200 with Sabouraud dextrose broth.   
 There were three gram-positive and three gram-negative bacteria, all of whom were both pathogenic and non-pathogenic 
(Table 3).  Bacteria were cultured on Lennox broth base agar medium at ~37 ºC. Prior to the assay, they were grown in a liquid 
Lennox broth base at 30 ºC and subsquently diluted to 1:9 with the same broth. 
 All microbial cultures were kept in M.L. Smith's laboratory at Carleton University (Ottawa, ON, Canada) and all transfers were 
done under sterile conditions and carried out under a biological containment hood.   
Table 3 - Source and infection type for the microbial strains used in this study. 
 
Species/strain Source1 Infection types 
Fungi   
Candida albicans (Robin) Berkhout  Systemic and subcutaneous  
    al-1 (wild type) OGH-308-1329  
    CN1A (erg-, azole resistant) N. D. Lees  
    D10  (erg-, azole resistant) N. D. Lees  
Cryptococcus neoformans 
(Sanfelice) Vuillemin 
OMH-FR2704 Systemic and subcutaneous, 
menigingoencephalitis  
Saccharomyces cerevisia OCI-S288c Systematic, in immunocompromised 
patients 
Wangiella dermatitidis (Kano) 
McGinnis 
OMH-FR2236 Cutaneous, and central nervous system 
Gram-positive Bacteria   
Bacillus subtilis (Ehrenberg) Cohn ATCC 23857  
Enterococcus faecalis (Andrews 
and Horder) Sckleifer and Kilpper-
Balz 
ATCC 29055  
Listeria innocua Seeliger ATCC 51742 Non-pathogenic, related to L. 
monocytogenis which causes listeriosis 
Gram-negative Bacteria   
Escherichia coli (Migula) 
Castellani and Chalmers 
AB 1157 Unirary tract; diarrheal, renal, neurological 
complications 
Pseudomonas putida (Trevisan) 
Migula 
ATCC 12633  
Providencia stuartii ATCC 33672  
 
1OGH, Ontario General Hospital, Ottawa ON Canada; N.D. Lees, IUPUI, Indianapolis IN USA; OMH, Ontario Ministry of Health, Toronto ON Canada; OCI, 
Ontario Cancer Institute, Toronto ON Canada, ATCC American type culture collection. 
 
Disk diffusion bioassays 
 100 µL of diluted culture broth was spread onto Sabouraud dextrose agar plates and Lennox broth base agar plates, for fungi 
and bacteria respectively, using a sterile bent metal rod.  Three sterile 3M Whatman paper disks (7.5 mm diameter) were impregnated 
in increments with 2 mg of crude extract dissolved in solvent and placed face down on the inoculated surface after solvent was 
allowed to evaporated and the disk completely dry.  Plates were incubated at 30 ºC for two days and zones of inhibition measured in 
diameter.  Two known antifungal were used as positive controles: ketoconazole at 0.5 mg and berberine at 2 mg.  The first is a 
compound chemically synthesized and the second is a natural product drug produced by many plants of the Berberidaceae and 
Ranunculaceae family.  The solvent, 80 % ethanol, was used as the vehicle control. 
 This procedure differed to bacteria in extract concentrations and positive controls used.  Paper disks were impregnated with 20 
µg of crude extracts.  Positive controls were chloramphenicol, an antibiotic isolated from cultures of Streptomyces venezuelae and 
ampicillin, a penicillin produced by semi-synthesis, were used at the same concentrations as crude extract.  Plates were then incubated 
at 37 ºC for one day and zones of inhibition measured in diameter. 
 
 Results 
Pro-inflammatory and anti-inflammatory assay 
 16 ethanol extracts have been assayed for immunomodulatory activity (figure 1).  Six extracts displayed important anti-
inflammatory activity: Chacbolie kejen, Kum pim, Roc chit cuan, Xa’ab maus, Birritaq, and Ik kejen.  Of particular interest, Xa’ab 
maus, Birritaq, and Ik kejen are capable of returning TNF-alpha levels to that of the unstimulated control.  At the highest 
concentration tested, these extracts display activity similar to that of the positive control, parthenolide. 
 16 ethanol extracts were also assayed for pro-inflammatory activity (figure 2).  Three extracts displayed moderate pro-
inflammatory activity: Ixcua ajaw chan, Bak nel k’ejen, and Ixcua’ li k’uch.  At the highest concentration tested, these extracts were 
able to stimulate the production of TNF-alpha to approximately ¾ the level seen in the positive control Echinacea purpurea. 
 
Disk diffusion bioassays (Michel Rapinski) 
21 ethanol extracts have been assayed for anti-microbial activity.  Results in table 4 show a great diversity of inhibition 
between all plant species and all fungal species.  Multiple comparisons show that most of the plants with inhibitory activity find 
themselves within a range that  is statistically insignificant from the majority of the other plants.  Although their zones of inhibition do 
not match up to those of the positive controls, their value often exceeds a quarter of those of the pure compound controls.  In certain 
instances, such is the case for C. albicans D10, C. albicans Al1 and C. neoformans, the inhibition of the crude plant extracts may 
sometimes exceed half of that of the positive controls.  In three fungal species, one plant, Ik Kejen, showed inhibition comparable to 
those of the controls and in all fungal species, maintained the largest zones of inhibition. 
 Results in table 5 shows that crude extracts were active against one gram-positive bacterium, E. faecalis, and two gram-
negative bacteria, P. putida and P. stuartii.  Zones of inhibition nearly half of those of the positive controls.  Zones of inhibition for 
the controls, on the other hand, were also variable.  Ampicillin showed little or no inhibition in three bacteria species, including P. 
stuartii, which simply indicates the bacteria's resistance.  But what is more surprising is that crude extracts which showed inhibitory 
activity for P. stuartii had zones of inhibition which were statistically insignificant from chloramphenicol. 
 
Future work 
 The remaining plant extracts are in the process of being evaluated for their immunomodulatory activity.  These laboratory 
experiments will be carried out over the next year with the funding of NSERC. 
  
 


























































































































































































































































































Table 4 - Mean zone of inhibition (mm) ± standard error of 21 ethanol extracts and controls for 6 yeast-like fungi.  Zones of inhibition 
are represented as diameter and means (n = 3) were statistically differentiated by Tukey's test of multiple comparision. 
 
 C. albicans D10 C. albicans Al1 C. albicans CN1A S. cereviseae C. neoformans W. dermatitidis 
 
Birritaq 0,00 g ± 0,00 0,00 g ± 0,00 10,42 ± 0,55 0,00 g ± 0,00 0,00 e ± 0,00 0,00 d ± 0,00 
Mai Pim 0,00 g ± 0,00 8,00 f ± 0,00 9,00 ± 0,29 8,83 f ± 0,30 0,00 e ± 0,00 9,75 bc ± 0,80 
Rixij Tzunum 0,00 g ± 0,00 13,83 d ± 0,17 14,25 ± 0,38 13,83 cd ± 0,93 0,00 e ± 0,00 10,83 bc ± 0,33 
Kum Pim 11,08 c ± 0,42 9,92 ef ± 0,67 10,08 ± 0,17 11,67 def ± 1,01 0,00 e ± 0,00 12,50 b ± 1,01 
Mes' B'eel 9,58 cef ± 0,58 9,58 ef ± 0,71 9,50 ± 0,25 10,5 ef ± 0,52 0,00 e ± 0,00 10,67 bc ± 0,36 
Ixcua Ajaw Chan 8,67 ef ± 0,44 8,75 ef ± 0,29 10,00 ± 0,66 10,17 ef ± 0,17 0,00 e ± 0,00 10,50 bc ± 1,32 
Pa' Ulul 8,00 f ± 0,29 8,92 f ± 0,36 8,50 ± 0,00 0,00 g ± 0,00 0,00 e ± 0,00 8,75 c ± 0,43 
Bak Nel K'ejen 11,00 cd ± 0,38 10,75 df ± 0,14 8,50 ± 0,14 9,75 ef ± 0,14 0,00 e ± 0,00 10,50 bc ± 0,87 
Chacbolie K'ejen  9,50 cef ± 0,29 9,33 ef ± 0,44 9,58 ± 0,17 9,92 ef ± 0,60 0,00 e ± 0,00 9,17 c ± 0,44 
Ixcua' Li K'uch 10,83 cd ± 0,96 11,08 df ± 0,36 10,08 ± 0,30 11,67 def ± 1,01 0,00 e ± 0,00 10,50 bc ± 0,29 
Jolom chacmut #1 11,58 c ± 0,33 13,00 de ± 0,38 0,00 ± 0,00 0,00 g ± 0,00 8,50 d ± 4,27 10,92 bc ± 0,42 
Xa'ab Maus 10,67 cde ± 0,44 15,33 bc ± 2,03 0,00 ± 0,00 0,00 g ± 0,00 15,08 c ± 0,36 11,08 bc ± 0,08 
Ruxb'i'kaak #2 10,83 cd ± 0,55 12,78 def ± 2,58 8,75  ± 0,14 0,00 g ± 0,00 12,33 cd ± 0,65 10,25 bc ± 0,58 
Ik Kejen 16,17 b ± 0,22 19,08 ab ± 0,17 17,50 c ± 0,38 20,25 b ± 0,38 12,08 cd ± 0,22 11,42 bc ± 0,36 
Par' I' Pim 8,50 ef ± 0,29 13,08 de ± 0,68 12,17 ef ± 0,36 0,00 g ± 0,00 14.00 cd ± 0,38 10,42 bc ± 0,96 
Jolom chacmut #2 8,50 ef ± 0,29 13,17 de ± 0,08 12,00 efgh ± 0,80 0,00 g ± 0,00 16,67 c ± 0,55 0,00 d ± 0,00 
Ruxb'i'kaak #1 8,92 def ± 0,36 13,83 de ± 2,05 12,50 def ± 0,29 0,00 g ± 0,00 16,42 c ± 0,98 0,00 d ± 0,00 
Ruj i rak' aj tza 9,42 cef ± 0,42 14,58 cd ± 1,24 11,50 fgh ± 0,29 12,42 ce ± 1,58 14,25 v ± 0,25 0,00 d ± 0,00 
Roq chit cuan #1  0,00 g ± 0,00 12,83 df ± 0,51 13,67 de ± 0,36 0,00 g ± 0,00 11,67 cd ± 0,74 0,00 d ± 0,00 
Ixqu'uq Mo'coch 0,00 g ± 0,00 8,75 f ± 0,38 11,17 fgh ± 0,30 15,17 c ± 0,68 14,75 c ± 1,52 0,00 d ± 0,00 
Kolaras 10,17 ce ± 0,22 0,00 g ± 0,00 10,58 fgh ± 0,22 11,58 def ± 1,17 15,83 c ± 0,44 0,00 d ± 0,00 
Ketoconazole 26,50a ± 0,50 23,08 a ± 0,08 42,17 a ± 0,74 34.00 a ± 0,14  39.17 a ± 0,83 50 a ± 0  
Berberine 15,50 b ± 0,52 20,08 ab ± 0,33 23,00 b ± 0,38 20,58 b ± 0,55 25,83 b ± 0,87 50 a ± 0  
80 % Ethanol 0,00 g ± 0,00 0,00 g ± 0,00 9,08 ± 0,08 0,00 g ± 0,00 0,00 e ± 0,00 0,00 d ± 0,00 
 
 
Table 5 - Mean zone of inhibition (mm) ± standard error of 21 ethanol extracts and controls for 3 gram-positive and 3 gram-negative 






 B. subtilis E. faecalis L. innocua E. coli P. putida P. stuartii 
Birritaq 0,00 b ± 0,00  0,00 f ± 0,00 0,00 c ± 0,00  0,00 c ± 0,00 8,00 c ± 0,00 0,00 d ± 0,00 
 Mai Pim 0,00 b ± 0,00 0,00 f ± 0,00 0,00 c ± 0,00  0,00 c ± 0,00 8,00 c  ± 0,00 0,00 d ± 0,00 
 Rixij Tzunum 0,00 b ± 0,00 0,00 f ± 0,00 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 0,00 d ± 0,00 
 Kum Pim 0,00 b ± 0,00 0,00 f ± 0,00 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 0,00 d ± 0,00 
 Mes' B'eel 0,00 b ± 0,00 0,00 f ± 0,00 0,00 c ± 0,00  0,00 c ± 0,00 8.33 c ± 0,17 0,00 d ± 0,00 
 Ixcua Ajaw Chan 0,00 b ± 0,00 0,00 f ± 0,00 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 0,00 d ± 0,00  Pa' Ulul 0,00 b ± 0,00 0,00 f ± 0,00 0,00 c ± 0,00  0,00 c ± 0,00 8.33 c ± 0,17 0,00 d ± 0,00  
Bak Nel K'ejen 0,00 b ± 0,00 10,75 c ± 0,25 0,00 c ± 0,00  0,00 c ± 0,00 8.33 c ± 0,17 0,00 d ± 0,00  
Chacbolie K'ejen  0,00 b ± 0,00 9,08 de ± 0,17 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 0,00 d ± 0,00  
Ixcua' Li K'uch 0,00 b ± 0,00 9,58 cd ± 0,36 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 0,00 d ± 0,00 
  Jolom chacmut #1 0,00 b ± 0,00 8,75 de ± 0,14 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 8,00 c ± 0,00 
 Xa'ab Maus 0,00 b ± 0,00 8,50 de ± 0,25 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 9,00 ba ± 0,14 
Ruxb'i'kaak #2 0,00 b ± 0,00 9,25 de ± 0,25 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 8,17 bc ± 0,17 
Ik Kejen 0,00 b ± 0,00 9,33 de ± 0,46 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 9,17 a ± 0,22 
Par' I' Pim 0,00 b ± 0,00 9,17 de ± 0,22 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 0,00 d ± 0,00 
Jolom chacmut #2 0,00 b ± 0,00 8,50 de ± 0,50 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 8,33 bc ± 0,08 
Ruxb'i'kaak #1 0,00 b ± 0,00 8,92 de ± 0,08 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 8,42 ac ± 0,22 
Ruj i rak' aj tza 0,00 b ± 0,00 9,08 de ± 0,30 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 9,25 a ± 0,43 
Roq chit cuan #1  0,00 b ± 0,00 8,92 de ± 0,08 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 8,58 ca ± 0,46 
Ixqu'uq Mo'coch 0,00 b ± 0,00 9,08 de ± 0,17 0,00 c ± 0,00  0,00 c ± 0,00 8.33 c ± 0,17 0,00 d ± 0,00 
Kolaras 0,00 b ± 0,00 8,33 e ± 0,17 0,00 c ± 0,00  0,00 c ± 0,00 8.00 c ± 0,00 0,00 d ± 0,00 
      b    b         b       
 
Ampicillin 0,00 b ± 0,00 22,33 a ± 0,08 24,50 a ± 1,23  9,42 b ± 0,17 19,42 a ± 1,21 0,00 d ± 0,00 
80 % Ethanol 0,00 b ± 0,00 0,00 f ± 0,00 0,00 c ± 0,00  0,00 c ± 0,00 0,00 d ± 0,00 0,00 d ± 0,00 
 
 
